Advertisement

Viral Vaccines: Various Cell Substrates and Long-Term Prospective Studies

  • Ruth L. Kirschstein
  • John C. Petricciani
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 31)

Abstract

We will attempt to give an overview of the developments in the use of various cell substrates for the production of viral vaccines that has led to the present thinking of the regulatory agency of the United States, the Division of Biologics Standards (DBS), concerning such substrates. As such, it is a synthesis of information previously presented by many others and, also, of data derived from studies performed by others under contract funds from DBS. It is hoped in this way to make you aware of the practicalities that face a regulatory agency in the decision-making processes.

Keywords

Viral Vaccine Exchange Transfusion Measle Vaccine Cell Substrate Foamy Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    HULL, R.N., MINNER, J.R. & SMITH, J.W. Am. J. Hyg. 63:204, 1956.PubMedGoogle Scholar
  2. 2.
    HULL, R.N. & MINNER, J.R. Ann. N.Y. Acad. Sci. 67:413, 1957.PubMedCrossRefGoogle Scholar
  3. 3.
    HULL, R.N., MINNER, J.R. MASCOLI, C.C. Am. J. Hyg. 68: 31, 1958.PubMedGoogle Scholar
  4. 4.
    RUSTIGIAN, R., JOHNSTON, P. & REIHART, H. Proc. Soc. Exper. Biol. Med. 88:8, 1955.Google Scholar
  5. 5.
    MALHERBE, H. & HARWIN, R. Brit. J. Exper. Path. 38:539, 1957.Google Scholar
  6. 6.
    U.S. Department of Health, Education and Welfare, United States Public Health Service Regulations for the Manufacture of Biological Products, Title 42, Part 73, revised 1961.Google Scholar
  7. 7.
    SWEET, B.H. & Hilleman, M.R. Proo. Soo. Exper. Biol. Med. 105:420, 1960.Google Scholar
  8. 8.
    ROWE, W.P., HARTLEY, J.W., CRAMBLETT, H.G. & MASTROTA, F.M. Am. J. Hyg. 67:37, 1958.Google Scholar
  9. 9.
    ASHKENASCZI, A. & MELNICK, J.L. Am. J. Clin. Path. 38:209, 1962.Google Scholar
  10. 10.
    EDDY, B.E., BORMAN, G.S., GRUBBS, G. & YOUNG, R.D. Virology17:63, 1962.CrossRefGoogle Scholar
  11. 11.
    EDDY, B.E., BORMAN, G.S., BERKELEY, W. & YOUNG, R.D. Proc. Soc. Exper. Biol. Med. 107:191, 1961.Google Scholar
  12. 12.
    KOPROWSKI, H., PONTéN, J.A., JENSEN, F., RAVDIN, R.G., MOORHEAD, P. & SAKSELA, E. J. Cell. Comp. Physiol. 59: 281, 1962.CrossRefGoogle Scholar
  13. 13.
    RABSON, A.S. & KIRSCHSTEIN, R.L. Proc. Soc. Exper. Biol. Med. 111:323, 1962.Google Scholar
  14. 14.
    SHEIN, H.M. & ENDERS, J.F. Proc. Nat. Acad. Sci. 48:1164, 1962.PubMedCrossRefGoogle Scholar
  15. 15.
    BLACK, P.H. Virology 28:760, 1966.PubMedCrossRefGoogle Scholar
  16. 16.
    GERBER, P., HOTTLE, G.A. & GRUBBS, R.E. Proc. Soc. Exper. Biol. Med. 108:203, 1961.Google Scholar
  17. 17.
    FRAUMENI, J.F., EDERER, F. & MILLER, R.W. J.A.M.A. 185: 713, 1963.PubMedCrossRefGoogle Scholar
  18. 18.
    FRAUMENI, J.F., STARK, C.R., GOLD, E. & LEPOW, M.L. Science 167:59, 1970.PubMedCrossRefGoogle Scholar
  19. 19.
    KAPLAN, H.S. Nat. Cancer Inst. Mono. 4:141, 1960.Google Scholar
  20. 20.
    U.S. Department of Health, Education and Welfare, United States Public Health Service Regulations for the Manufacture of Biological Products, Title 42, Part 73, revised 1963.Google Scholar
  21. 21.
    HAYFLICK, L. & MOORHEAD, P.S. Exper. Cell Res. 25:585, 1961.CrossRefGoogle Scholar
  22. 22.
    ROBBINS, F.C. Nat. Cancer Inst. Mono. 29:457, 1968.Google Scholar
  23. 23.
    FOX, J.P. Nat. Cancer Inst. Mono. 29:459, 1968.Google Scholar
  24. 24.
    MURRAY, R. Nat. Cancer Inst. Mono. 29:460, 1968.Google Scholar
  25. 25.
    U.S. Department of Health, Education and Welfare, United States Public Health Service Regulations for the Manufacture of Biological Products, Title 42, Part 73, revised 1969.Google Scholar
  26. 26.
    MILLER, R.W. Nat. Cancer Inst. Mono. 29:433, 1968.Google Scholar
  27. 27.
    SABIN, A.B. Discussion, Proceedings of the International Conference on Rubella Immunization, p. 378. National Institute of Health, Bethesda, Md., Feb. 18–20, 1969.Google Scholar
  28. 28.
    MERCHANT, D.J. Nat. Cancer Inst. Mono. 29:583, 1968.Google Scholar
  29. 29.
    WALLACE, R.E., VASINGTON, P.J. & PETRICCIANI, J.C. Diploid cell lines from sub-human primates as substrates for vaccine production, Twelfth International Congress of the International Association of Microbiological Societies, Permanent Section for Microbiological Standardization, September, 1971, Annecy, France.Google Scholar
  30. 30.
    PETRICCIANI, J.C., HOPPS, H.E. & LORENZ, D.E. Science 174: 1025, 1971.PubMedCrossRefGoogle Scholar
  31. 31.
    WALLACE, R.E., VASINGTON, P.J., PETRICCIANI, J.C., HOPPS, H.E., & LORENZ, D.E. (To be published.)Google Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • Ruth L. Kirschstein
    • 1
  • John C. Petricciani
    • 1
  1. 1.Laboratory of Pathology, Division of Biologies Standards, U.S. Public Health Service, Department of Health, Education and WelfareNational Institutes of HealthBethesdaU.S.A.

Personalised recommendations